Advertisement

Topics

Nektar's IL-2 Impresses In Combination With Bristol's Opdivo

15:03 EST 14 Nov 2017 | SCRIP

Nektar's IL-2 stimulating agonist NKTR-214 combines well with Bristol's Opdivo in Phase I PIVOT-02 study presented at SITC meeting in...

      

Related Stories

 

Original Article: Nektar's IL-2 Impresses In Combination With Bristol's Opdivo

NEXT ARTICLE

More From BioPortfolio on "Nektar's IL-2 Impresses In Combination With Bristol's Opdivo"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...